Abiopharma

PETROS PHARMACEUTICALS, INC. (PTPI)

Symbol	PTPI
Name	PETROS PHARMACEUTICALS, INC.
Sector	UNDEFINED
Region	North America
Industry	-
Address	10036 United States NY 1185 Avenue of the Americas 3rd Floor
Telephone	(973) 242-0005
Fax	—
Email	—
Website	https://www.petrospharma.com/
Incorporation	US
Incorporated On	2020
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC;NASDAQ
Auditor	CBIZ CPAs P.C.;
Audit Status	AUDITED
Reporting Status	U.S. Reporting: SEC Reporting
CIK	0001815903
Description	Petros Pharmaceuticals, Inc. is committed to the goal of becoming a leading innovator in the emerging $38 billion self-care market by providing expanded access to key prescription pharmaceuticals as OTC treatment options. The Company is currently developing a proprietary SaaS platform designed to assist pharmaceutical companies in meeting FDA standards to assist in the Rx-to-OTC switch. Additional info from OTC: Petros Pharmaceuticals, Inc. is committed to the goal of becoming a leading innovator in the emerging $38 billion self-care market by providing expanded access to key prescription pharmaceuticals as OTC treatment options. The Company is currently developing a proprietary SaaS platform designed to assist pharmaceutical companies in meeting FDA standards to assist in the Rx-to-OTC switch.

2026-02-17 12:51

New Form SCHEDULE 13G/A - Petros Pharmaceuticals, Inc. Filed: 2026-02-17 AccNo: 0000930413-26-000426 Size: 15 KB

2026-01-06 22:30

Boctor Fady 🟢 acquired 500.0K shares of Petros Pharmaceuticals, Inc. (PTPI) Transaction Date: Jan 02, 2026 | Filing ID: 001417

2026-01-02 22:00

Director Silverman Joshua 🟢 acquired 4.4M shares of Petros Pharmaceuticals, Inc. (PTPI) Transaction Date: Jan 02, 2026 | Filing ID: 000238

2026-01-02 22:00

(99% Neutral) Petros Pharmaceuticals, Inc. (PTPI) Announces Executive Changes

2026-01-02 22:00

Director Bernstein Bruce 🟢 acquired 1.9M shares of Petros Pharmaceuticals, Inc. (PTPI) Transaction Date: Jan 02, 2026 | Filing ID: 000233

2025-11-20 19:51

New Form 25-NSE - Petros Pharmaceuticals, Inc. Filed: 2025-11-20 AccNo: 0001354457-25-001163 Size: 5 KB

2025-11-13 21:20

Petros Pharmaceuticals Inc. (PTPI) Files Form 10-Q

2025-11-07 22:00

(99% Neutral) Petros Pharmaceuticals, Inc. (PTPI) Files Form 8-K

2025-08-15 12:01

New Form SCHEDULE 13G/A - Petros Pharmaceuticals, Inc. Filed: 2025-08-15 AccNo: 0000930413-25-002483 Size: 15 KB

2025-06-25 13:16

Petros Pharmaceuticals Announces Deconsolidation of Metuchen Pharmaceuticals Subsidiary, Strengthening its Balance Sheet and Improving the Companys Equity Position